Breaking News
Get 45% Off 0
Is it finally time to sell Nvidia ahead of earnings?
Read More

Stock Markets Analysis & Opinion

Contribute
Zacks Investment Research
International Business Aids NuVasive, Pricing Woe Remains By Zacks Investment Research - Feb 21, 2018

On Feb 19, we issued an updated research report on NuVasive, Inc. (NASDAQ:NUVA) . While the strong Spine market spells huge scope for the stock, pricing and payers pressure come as major headwinds....

Zacks Investment Research
5 Best No-Load Mutual Funds Investors Will Love By Zacks Investment Research - Feb 21, 2018

Higher bond yields continue to weigh on equities following concerns over increased inflation, raising skepticism in the market. Additionally, upbeat economic data including a strong jobs report...

Zacks Investment Research
Medicines Company (MDCO) Reports Q4 Loss, Revenues Slump Y/Y By Zacks Investment Research - Feb 21, 2018

The Medicines Company (NASDAQ:MDCO) reported fourth-quarter 2017 loss of $2.19 per share. The Zacks Consensus Estimate stood at a loss of $1.48.However, excluding the impact of one-time and special...

Zacks Investment Research
Acadia Healthcare (ACHC) Beats On Earnings & Revenues In Q4 By Zacks Investment Research - Feb 21, 2018

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) reported fourth-quarter 2017 adjusted earnings of 61 cents per share, which beat the Zacks Consensus Estimate by 10.8%. Moreover, earnings improved 3.4%...

Zacks Investment Research
Jobless Claims 222K: Brand New Retro By Zacks Investment Research - Feb 21, 2018

Thursday, February 22, 2018Ahead of today’s opening bell, Initial Jobless Claims results hit the tape, as they do every Thursday morning. And as we’ve seen for the past several weeks...

Continue with Apple
Continue with Google
or
Sign up with Email